The procedure was performed at the University Hospital of Tübingen in Germany. Professor Martin U. Schuhmann, a pediatric neurosurgeon, performed the biopsy.
“Performing a successful biopsy is the first step to finding a biological cure which scientists believe is the only chance to beat this terrible disease,” said Ori Hadomi, CEO of the company. “Mazor Robotics’ mission is to make a difference.”
More articles on devices:
K2M sets follow-on offering at $18.75 per share — 5 things to know
Implanet’s JAZZ technology receives intellectual patent protection in Europe
FTC makes second request for additional information on Wright Medical-Tornier merger — 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
